/
/
/

Alivus Life Sciences Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)1,447.60
Volume (₹)5.25 L
High (₹)1,501.50
Upper Circuit1,737.10
Low (₹)1,440.00
Lower Circuit1,158.10
Prev Close1,447.60
52W High (₹)1,505.00
Price1,481.30
52W Low (₹)819.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)17842.60 Cr
Div. Yield (%)0.34
PE Ratio26.64
Debt to Equity0.00
Price to Book3.60
Book Value270.90
EPS (TTM)54.47
Face Value2.00
ROE (%)18.41

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
ALIVUSNSE
LTP
1W Low
1W High
Market cap (₹)
1769.9+8.9 (0.51%)
1722
1855
4,24,202Cr
10064+400 (4.14%)
9621.50
10064
2,64,141Cr
4650+70 (1.53%)
4532
4675
1,74,402Cr
2323+79 (3.52%)
2206.10
2441.90
1,26,811Cr
1240.6+56.2 (4.75%)
1182
1254.20
1,23,685Cr
1368.3+23.3 (1.73%)
1336.70
1368.30
1,11,868Cr
1396.9+38.9 (2.86%)
1357
1396.90
1,11,650Cr
2475+5.7 (0.23%)
2457.90
2528
1,02,196Cr
1694.5+34.6 (2.08%)
1647.20
1697.40
96,951Cr
2015.9+26 (1.31%)
1974
2033.80
91,301Cr
1481.3+83.9 (6.00%)
1380
1505
17,843Cr

Key Highlights of Alivus Life Sciences Ltd Balance Sheet

Alivus Life Sciences Ltd balance sheet discloses shareholders' funds of ₹24.55Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹24.55Cr, and the reserves and surplus of the company is ₹3300.34Cr.

The company has its non-current liabilities with total liabilities of ₹4157.1Cr as of 2026-03-31.

The current liabilities are ₹682.24Cr as of 2026-03-31. At the same time, current assets are ₹2823.56Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹7.7Lakh and tangible assets of ₹1037.55Cr, provided in the Alivus Life Sciences Ltd financial statements.